GPT and blood coagulation disease: The treatment was stopped because of increasing liver enzymes, with aspartate aminotransferase (AST) of 248 U/L, reference range 14-36 U/L, and alanine aminotransferase (ALT) of 131 U/L, reference range 4-35 U/L, and mild coagulation disorder with hypofibrinogenemia (190 mg/dl, reference range 200-393 mg/dl), but without bleeding signs.